Medication abortion employing routine sequential measurements of serum hCG and sonography only when indicated

Wesley Clark, Tanya Panton, Louisa Hann, Marji Gold

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Objectives: This study was designed to demonstrate the safety and efficacy of providing medication abortion in a primary care site without routine use of pre- and postprocedure transvaginal sonography. Methods: We performed a retrospective record review of 172 consecutive patients choosing medication abortion at our clinic. Our protocol used sonography only as needed for specific indications. All patients were intended to be followed up with serum human chorionic gonadotropin (hCG) testing pre- and posttreatment. Results: Of the 151 patients not lost to follow-up, 96 (63%) had pretreatment sonography according to protocol or physician preference and 55 did not. Ninety-nine percent (95/96) of those receiving initial sonography had a successful, and uneventful, medication abortion treatment, while 98.2% (54/55) of those not receiving an initial sonography did so. This difference was not statistically significant (.597 by one-sided Fisher's Exact Test). All 119 of the women who did not receive postabortion sonography aborted completely. Only 4 of the 91 women who had both pre- and postprocedure hCG measurements, all of whom aborted successfully, had follow-up-to-initial hCG ratios of greater than 0.2 (20%). Conclusion: Using a clinical protocol that involves obtaining pre- and posttreatment serum hCG measurements, with sonograms only when indicated, has similar outcomes to a protocol that uses mandatory pre- and posttreatment sonograms.

Original languageEnglish (US)
Pages (from-to)131-135
Number of pages5
JournalContraception
Volume75
Issue number2
DOIs
StatePublished - Feb 2007

Fingerprint

Chorionic Gonadotropin
Ultrasonography
Serum
Aftercare
Lost to Follow-Up
Clinical Protocols
Primary Health Care
Physicians
Safety

Keywords

  • Follow-up
  • Gestational age
  • Medical abortion
  • Serum hCG
  • Sonography
  • Ultrasound

ASJC Scopus subject areas

  • Medicine(all)
  • Obstetrics and Gynecology

Cite this

Medication abortion employing routine sequential measurements of serum hCG and sonography only when indicated. / Clark, Wesley; Panton, Tanya; Hann, Louisa; Gold, Marji.

In: Contraception, Vol. 75, No. 2, 02.2007, p. 131-135.

Research output: Contribution to journalArticle

Clark, Wesley ; Panton, Tanya ; Hann, Louisa ; Gold, Marji. / Medication abortion employing routine sequential measurements of serum hCG and sonography only when indicated. In: Contraception. 2007 ; Vol. 75, No. 2. pp. 131-135.
@article{48a476b4c3f04871a8991d5e8a1dd2a7,
title = "Medication abortion employing routine sequential measurements of serum hCG and sonography only when indicated",
abstract = "Objectives: This study was designed to demonstrate the safety and efficacy of providing medication abortion in a primary care site without routine use of pre- and postprocedure transvaginal sonography. Methods: We performed a retrospective record review of 172 consecutive patients choosing medication abortion at our clinic. Our protocol used sonography only as needed for specific indications. All patients were intended to be followed up with serum human chorionic gonadotropin (hCG) testing pre- and posttreatment. Results: Of the 151 patients not lost to follow-up, 96 (63{\%}) had pretreatment sonography according to protocol or physician preference and 55 did not. Ninety-nine percent (95/96) of those receiving initial sonography had a successful, and uneventful, medication abortion treatment, while 98.2{\%} (54/55) of those not receiving an initial sonography did so. This difference was not statistically significant (.597 by one-sided Fisher's Exact Test). All 119 of the women who did not receive postabortion sonography aborted completely. Only 4 of the 91 women who had both pre- and postprocedure hCG measurements, all of whom aborted successfully, had follow-up-to-initial hCG ratios of greater than 0.2 (20{\%}). Conclusion: Using a clinical protocol that involves obtaining pre- and posttreatment serum hCG measurements, with sonograms only when indicated, has similar outcomes to a protocol that uses mandatory pre- and posttreatment sonograms.",
keywords = "Follow-up, Gestational age, Medical abortion, Serum hCG, Sonography, Ultrasound",
author = "Wesley Clark and Tanya Panton and Louisa Hann and Marji Gold",
year = "2007",
month = "2",
doi = "10.1016/j.contraception.2006.08.001",
language = "English (US)",
volume = "75",
pages = "131--135",
journal = "Contraception",
issn = "0010-7824",
publisher = "Elsevier USA",
number = "2",

}

TY - JOUR

T1 - Medication abortion employing routine sequential measurements of serum hCG and sonography only when indicated

AU - Clark, Wesley

AU - Panton, Tanya

AU - Hann, Louisa

AU - Gold, Marji

PY - 2007/2

Y1 - 2007/2

N2 - Objectives: This study was designed to demonstrate the safety and efficacy of providing medication abortion in a primary care site without routine use of pre- and postprocedure transvaginal sonography. Methods: We performed a retrospective record review of 172 consecutive patients choosing medication abortion at our clinic. Our protocol used sonography only as needed for specific indications. All patients were intended to be followed up with serum human chorionic gonadotropin (hCG) testing pre- and posttreatment. Results: Of the 151 patients not lost to follow-up, 96 (63%) had pretreatment sonography according to protocol or physician preference and 55 did not. Ninety-nine percent (95/96) of those receiving initial sonography had a successful, and uneventful, medication abortion treatment, while 98.2% (54/55) of those not receiving an initial sonography did so. This difference was not statistically significant (.597 by one-sided Fisher's Exact Test). All 119 of the women who did not receive postabortion sonography aborted completely. Only 4 of the 91 women who had both pre- and postprocedure hCG measurements, all of whom aborted successfully, had follow-up-to-initial hCG ratios of greater than 0.2 (20%). Conclusion: Using a clinical protocol that involves obtaining pre- and posttreatment serum hCG measurements, with sonograms only when indicated, has similar outcomes to a protocol that uses mandatory pre- and posttreatment sonograms.

AB - Objectives: This study was designed to demonstrate the safety and efficacy of providing medication abortion in a primary care site without routine use of pre- and postprocedure transvaginal sonography. Methods: We performed a retrospective record review of 172 consecutive patients choosing medication abortion at our clinic. Our protocol used sonography only as needed for specific indications. All patients were intended to be followed up with serum human chorionic gonadotropin (hCG) testing pre- and posttreatment. Results: Of the 151 patients not lost to follow-up, 96 (63%) had pretreatment sonography according to protocol or physician preference and 55 did not. Ninety-nine percent (95/96) of those receiving initial sonography had a successful, and uneventful, medication abortion treatment, while 98.2% (54/55) of those not receiving an initial sonography did so. This difference was not statistically significant (.597 by one-sided Fisher's Exact Test). All 119 of the women who did not receive postabortion sonography aborted completely. Only 4 of the 91 women who had both pre- and postprocedure hCG measurements, all of whom aborted successfully, had follow-up-to-initial hCG ratios of greater than 0.2 (20%). Conclusion: Using a clinical protocol that involves obtaining pre- and posttreatment serum hCG measurements, with sonograms only when indicated, has similar outcomes to a protocol that uses mandatory pre- and posttreatment sonograms.

KW - Follow-up

KW - Gestational age

KW - Medical abortion

KW - Serum hCG

KW - Sonography

KW - Ultrasound

UR - http://www.scopus.com/inward/record.url?scp=33846254188&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846254188&partnerID=8YFLogxK

U2 - 10.1016/j.contraception.2006.08.001

DO - 10.1016/j.contraception.2006.08.001

M3 - Article

VL - 75

SP - 131

EP - 135

JO - Contraception

JF - Contraception

SN - 0010-7824

IS - 2

ER -